Share fraud includes scams where investors are called out of the blue and offered shares that often turn out to be worthless or non-existent, or an inflated price for shares they own. These calls come from fraudsters operating in 'boiler rooms' that are mostly based abroad.
The following information is disclosed in accordance with Rule 26 of the AIM Rules:
10 Mar 2017 Form of Proxy for AGM to be held on 19 June 2017
04 Mar 2016 Form of Proxy for AGM held on 22 June 2016
09 June 2015 Notice of General Meeting held on 24 June 2015
09 June 2015 Form of Proxy for General Meeting held on 24 June 2015
05 Mar 2015 Notice of AGM held on 24 June 2015
05 Mar 2015 Form of Proxy for AGM held on 24 June 2015
18 Jun 2014 Notice of AGM held on 18 June 2014
18 Jun 2014 Form of Proxy for AGM held on 18 June 2014
20 Mar 2013 Notice of AGM held on 12 June 2013
20 Mar 2013 Form of Proxy for AGM held on 12 June 2013
28 Feb 2013 Notice of General Meeting held on 19 March 2013
28 Feb 2013 Form of Proxy for General Meeting held on 19 March 2013
26 Nov 2012 Notice of General Meeting held on 12 December 2012
26 Nov 2012 Form of Proxy for General Meeting held on 12 December 2012
27 Mar 2012 Notice of Annual General Meeting held on 14 June 2012
See About Us
The names of the directors and biographical details
Directors' responsibilities & Committees
Country of incorporation and main country of operation
Oxford Pharmascience Group Plc is incorporated in England & Wales (Registration Number 07036758) with England its main country of operation.
Current constitutional documents
Please click on the link below for the Articles of Association
Details of any other exchanges or trading platforms
The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue
As at 15 October 2016 the number of shares in issue was 1,205,661,619.
As at 15 October 2016, shareholders holding more than 3% of the share capital of Oxford Pharmascience Group Plc were:
|Holders > 3%||Shares||%|
|Woodford Investment Managers||401,597,920||33.31%|
|Mr R Griffiths||173,071,097||14.35%|
|Southern Fox Investments Ltd||51,000,000||4.23%|
|Mr R Quested||37,247,753||3.09%|
|Henderson Global Investors||37,000,000||3.07%|
Shares not in Public hands
In the terms of the AIM Rules published July 2016 and insofar as it is aware, at 15 October 2016, 70.11% of the Company's AIM securities were not held in public hands.
UK City Code on Takeovers and Mergers
As an AIM traded UK registered company, Oxford Pharmascience Group Plc is subject to the UK City Code on Takeovers and Mergers legislation.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
Please click on the link below to access the Company's Admission Document dated 08 February 2010.
You will need Adobe Acrobat Reader to view PDF documents. To download it for free please click on the logo.